Liang XL - Search Results

1

Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.

Su YD, Ma R, Fu YB, Wu HL, Liang XL, Liu YT, Yu Y, Yang ZR, Li Y. Su YD, et al. Among authors: liang xl. J Surg Oncol. 2024 Aug 25. doi: 10.1002/jso.27847. Online ahead of print. J Surg Oncol. 2024. PMID: 39183488

2

Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Su YD, Zhao X, Ma R, Fu YB, Yang ZR, Wu HL, Yu Y, Yang R, Liang XL, Du XM, Chen Y, Li Y. Su YD, et al. Among authors: liang xl. Int J Hyperthermia. 2023;40(1):2223374. doi: 10.1080/02656736.2023.2223374. Int J Hyperthermia. 2023. PMID: 37348853 Free article. Clinical Trial.

3

Etiological analysis of infection after CRS + HIPEC in patients with PMP.

Yang R, Zhao X, Fu YB, Lin YL, Ma R, Su YD, Wu HL, Liang XL, Li Y. Yang R, et al. Among authors: liang xl. BMC Cancer. 2023 Sep 26;23(1):903. doi: 10.1186/s12885-023-11404-1. BMC Cancer. 2023. PMID: 37752468 Free PMC article.

4

Long-term survival in patients with PMP: a single-institutional retrospective study from China.

Yang R, Fu YB, Li XB, Ma R, Su YD, Wu HL, Liang XL, Li Y. Yang R, et al. Among authors: liang xl. World J Surg Oncol. 2023 Oct 28;21(1):347. doi: 10.1186/s12957-023-03232-1. World J Surg Oncol. 2023. PMID: 37891655 Free PMC article.

5

Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome.

Liang XL, Su YD, Li XB, Fu YB, Ma R, Yang R, Wu HL, Li Y. Liang XL, et al. World J Surg Oncol. 2024 Jan 24;22(1):29. doi: 10.1186/s12957-024-03312-w. World J Surg Oncol. 2024. PMID: 38267958 Free PMC article.

6

Intraoperative urinary tract resection and construction in CRS + HIPEC procedures: a single center retrospective analysis.

Ji ZH, Fu YB, Liu G, Yu Y, Li B, Su YD, Yang R, Liang XL, Li Y. Ji ZH, et al. Among authors: liang xl. World J Surg Oncol. 2024 Jun 26;22(1):171. doi: 10.1186/s12957-024-03457-8. World J Surg Oncol. 2024. PMID: 38926860 Free PMC article.

7

Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review.

Liang XL, Li XB, Fu YB, Su YD, Ma R, Yang R, Wu HL, Li Y. Liang XL, et al. J Surg Oncol. 2024 Sep;130(3):533-542. doi: 10.1002/jso.27737. Epub 2024 Jul 31. J Surg Oncol. 2024. PMID: 39082465 Review.

8

Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: A single-center case-control study.

Liang XL, Su YD, Fu YB, Li XB, Ma R, Yang R, Wu HL, Li Y. Liang XL, et al. Eur J Surg Oncol. 2024 Nov;50(11):108692. doi: 10.1016/j.ejso.2024.108692. Epub 2024 Sep 14. Eur J Surg Oncol. 2024. PMID: 39298871

9

Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy.

Wu H, Wang Y, Lin Y, Ma R, Du X, Su Y, Yang R, Yang Z, Liang X, Zhang Y, Liang X, Ji Z, Lai C, Huang Y, Li Y. Wu H, et al. Cancer Biol Med. 2024 Nov 1;21(11):1078-94. doi: 10.20892/j.issn.2095-3941.2024.0218. Cancer Biol Med. 2024. PMID: 39485065 Free PMC article.

10

Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.

Liang XL, Su YD, Li XB, Fu YB, Ma R, Yang R, Wu HL, Cui YR, Li Y. Liang XL, et al. Ann Surg Oncol. 2024 Nov 13. doi: 10.1245/s10434-024-16485-1. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39538101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters